Clinical Trial Update: 11C-methionine in Diagnostics and Management of Glioblastoma Multiforme Patients (GlioMET) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating 11C-methionine for diagnostics and management of glioblastoma multiforme has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• 11C-methionine (carbon-11 methionine)

Snippet

Sponsor: Masaryk Memorial Cancer Institute | Conditions: Glioblastoma Multiforme | Phase 2 | Status: COMPLETED